Bradley Pharmaceuticals Derivative Action Dismissed
A state judge has dismissed a pending shareholder derivative action brought against former officers and directors of Bradley Pharmaceuticals Inc. that claimed they breached their fiduciary duties to the company by...To view the full article, register now.
Already a subscriber? Click here to view full article